首页> 外文期刊>Texas Heart Institute journal / >Valve-in-Valve-in-Valve transcatheter aortic valve implantation; to treat a degenerated surgical bioprosthesis in a subaortic position
【24h】

Valve-in-Valve-in-Valve transcatheter aortic valve implantation; to treat a degenerated surgical bioprosthesis in a subaortic position

机译:瓣膜中瓣膜经导管主动脉瓣植入;在主动脉下位置治疗退化的外科生物假体

获取原文
获取原文并翻译 | 示例

摘要

Transcatheter aortic valve implantation for aortic stenosis has evolved as an alternative treatment for patients who are at high or excessive surgical risk. We report the case of an 84-year-old man with a degenerated surgically implanted valve in a subaortic position (9 mm below the native annulus) who underwent "valve-in-valve" transcatheter aortic valve implantation with use of a Medtronic CoreValve system. We planned to deploy the Core-Valve at a conventional depth in the left ventricular outflow tract; we realized that this might result in paravalvular regurgitation, but it would also afford a "deep" landing site for a second valve, if necessary. Ultimately, we implanted a second CoreValve deep in the left ventricular outflow tract to seal a paravalvular leak. The frame of the first valve-positioned at the conventional depth-enabled secure anchoring of the second valve in a deeper position, which in turn effected successful treatment of the failing subaortic surgical prosthesis without paravalvular regurgitation.
机译:经导管主动脉瓣植入术已经发展成为具有高手术风险或高手术风险的患者的替代疗法。我们报道了一个84岁的男子的案例,该病人在主动脉下位置(自然环下方9毫米)具有退化的外科植入瓣膜,并使用Medtronic CoreValve系统进行了“瓣膜中”经导管主动脉瓣植入术。我们计划在左心室流出道的常规深度部署Core-Valve。我们意识到这可能会导致瓣膜返流,但是如果需要的话,它还会为第二个瓣膜提供一个“较深”的着陆点。最终,我们在左心室流出道深处植入了第二个CoreValve,以密封瓣周漏。将第一瓣膜的框架定位在常规的能够进行深度的深度上,从而将第二瓣膜牢固地锚定在更深的位置,这反过来又成功地治疗了主动脉瓣下手术失败的假体,而没有瓣周返流。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号